ClinicalTrials.gg
RecruitingNCT04031950Updated Nov 18, 2026

Clinical Evaluation of a Paediatric Sleep Diagnosis Technology

An observational study in Sleep Apnea, sponsored by Acurable Ltd.. Recruiting at 2 sites in United Kingdom. Open to participants aged 1 Year to 18 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Acurable Ltd. · Observational

How we know

From the registry’s dates

  • Started Feb 2020; still recruiting 6 years 9 months later.
Updated Nov 18, 2026Primary completion movedStudy completion moved+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
345
Ages
1 Year to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 36 studies in Sleep Apnea Syndromes with a site in United Kingdom — 7 open to participants now, 8 under way, 1 of them phase 3. Sleep Apnea Syndromes · United Kingdom.

Planned enrollment
4th of 14
345 · median 101
Started
2020
with 1 other
Observational
14 of 36
4 open now
Registered
21st of 36
by date
Lead sponsor
1 of 36
Acurable Ltd.

Among the 36 studies in Sleep Apnea Syndromes with a site in United Kingdom, this one is the 4th largest by planned enrollment of the 14 observational ones that give a count, is one of 2 that started in 2020, is one of 14 observational ones, and was the 21st registered.

Sleep Apnea Syndromes

1,085 studies on the registry are indexed under Sleep Apnea Syndromes; 172 are open to participants now.

Browse Sleep Apnea Syndromes studies →

Open to participants now

7 of the 36 studies in Sleep Apnea Syndromes with a site in United Kingdom are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 119 Sleep Apnea Syndromes studies recruiting now, 58 (49%) set no upper age limit and 37 (31%) stop at 75 or younger; 25 take children under 18; 28 take healthy volunteers.

This study: 1 Year to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 36 studies in Sleep Apnea Syndromes with a site in United Kingdom, or all of them as a file.
02

Study summary

The objective of this project is to gather research data and subsequently evaluate algorithms to demonstrate clinical efficacy of a novel sleep apnoea detection system in the paediatric population.

The Study will involve patients who will have been referred for diagnosis of sleep apnoea, and the ultimate aim will be to compare the output of a novel apnoea detection system against in -clinic polysomnography or cardio-respiratory polygraphy, assess acceptance of the novel system in the home environment, assess validity in patients on ventilation, and on a cohort with BMI SDS of 3 or more.

Read the detailed description

The objective of this project is to gather research data and subsequently evaluate algorithms to demonstrate clinical efficacy of a novel sleep apnoea detection system in the paediatric population.

The Study will involve patients who will have been referred for diagnosis of sleep apnoea, and the ultimate aim will be to compare the output of a novel apnoea detection system against in -clinic polysomnography or cardio-respiratory polygraphy, assess acceptance of the novel system in the home environment, assess validity in patients on ventilation, and on a cohort with BMI SDS of 3 or more.

Patients who are referred to the clinic for the first and second group will spend one night's sleep in the clinic for group 1 and group 2. They will wear a polysomnography or cardio-respiratory polygraphy system (current goldstandard) and the novel device. At the end of the trial, we will compare the diagnosis results from both systems.

Patients who are referred for home diagnosis of sleep apnoea or overnight oximetry at home (group 3) will wear the standard clinical sleep test system and the novel device. At the end of the trial, the acceptability of the novel device will be assessed.

Patients who are on mechanical ventilation and referred for diagnosis of sleep apnoea in hospital or at home will wear the standard clinical sleep test system and the novel device. At the end of the trial, the validity of the diagnosis from the novel device will be assessed.

Patients who are referred for either at home or in hospital diagnosis of sleep apnoea with a BMI SDS score of 3 or more will wear the standard clinical sleep test system and the novel device. At the end of the trial, we will compare the diagnosis results from both systems.

03

Conditions studied

  • Sleep Apnea
04

Who can participate

The criteria were revised on the registry on Nov 18, 2026. See what changed

Ages eligible
1 Year to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

all children who have been referred for a sleep test.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children older than one year old (older than eight years old for studies at-home) and below 18 years of age.
  • Children who have been referred to a sleep clinic due to suspicion of sleep apnoea.

Exclusion criteria

Exclusion Criteria:

  • Patients whose parents/legal guardians/carers are not fluent in English, or who have special communication needs.
  • Known allergy to the adhesive dressing.
  • Patients with physical or mental impairments who would be too distressed with additional sensors on themselves.
  • Patients with not enough space on the neck area to fit the sensor.
  • Clinical problem in the area in which the device will be attached, eg skin condition ●. For patients conducting the study at home, patients with neurocognitive impairments which may increase the risk of them putting the sensor in their mouth, who do not have overnight carers
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
345 participants (estimated)
Patient registry
No

Groups and cohorts

  • test group

    Test group will wear PSG

    Device: Novel wearable paediatric device

  • Novel wearable device

    THis group will wear the novel device

    Device: Novel wearable paediatric device

  • Home

    40 consecutive patients (plus/minus 30% to account for potential dropouts, invalid signals from the gold-standard), who will have been referred for at home diagnosis of sleep apnoea or overnight oximetry at home. Each site will recruit, in parallel, consecutive patients from the moment the first patient in this group is recruited at that site. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. Criteria for inclusion are children older than 8 years old and referral for overnight assessment for evaluation of possible sleep apnoea. Additionally, patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. This patient cohort will be used to assess the acceptance of the AcuPebble technology in the home environment.

    Device: Novel wearable paediatric device

  • Ventilation

    30 patients will be recruited (plus/minus 30% to account for potential dropouts, invalid signals from the gold-standard), who are on mechanical ventilation and have been referred for diagnosis of sleep apnoea. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. Criteria for inclusion are children older than 1 year old, referral for overnight assessment for evaluation or monitoring of sleep apnoea, and being on mechanical ventilation while conducting the study in hospital, or over 8 years old, referral for overnight assessment for evaluation or monitoring of sleep apnoea, and being on mechanical ventilation while conducting the study at home. Patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. These patients will be included in a final analysis of diagnostic validity.

    Device: Novel wearable paediatric device

  • High BMI

    75 patients will be recruited (plus/minus 30% to account for potential dropouts, or invalid signals from the gold-standard), who have a BMI SDS score of 3 or more and have been referred for either at-home or in-hospital diagnosis of sleep apnoea. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. If their study is to take place in the home, only children who are older than 8 will be included. If their study is to take place in hospital, children over the age of 1 will be included. Patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. These patients will be included in a final analysis of sensitivity and specificity for this cohort.

    Device: Novel wearable paediatric device

Interventions

  • DeviceNovel wearable paediatric device

    The patient will wear the novel wearable paediatric device at the same time as polysmnography

06

What researchers measure

Primary outcomes

  1. Specificity and sensitivity of novel device

    specificity and sensitivity of the output of the novel wearable device against polysomnography

    Time frame: 6 months

07

Study locations

2 of 2 sites recruiting
  • Sheffield Children Hospital
    Sheffield, S10 2TH, United Kingdom
    Recruiting
    • Orsina Dessi · Contactorsina@acurable.com · +447721 877020
    • Heather Elphick · Principal investigator
  • Southampton Children's Hospital
    Southampton, United Kingdom
    Recruiting
    • Orsina Dessi · Contact
    • Hazel Evans · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2020 (actual). Primary completion is estimated for Oct 2027, 91 months after the start.

Of 149 observational studies under Sleep Apnea Syndromes, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 83. This study's planned 91 months is above that.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: primary completion Oct 2025 → Oct 2027 and completion Dec 2025 → Oct 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 23, 2019
First posted
Jul 25, 2019
StartActual
Feb 19, 2020
Primary completionEst.
Oct 14, 2027was Oct 2025
CompletionEst.
Oct 14, 2027was Dec 2025
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Oct 30, 2025→Oct 14, 2027
Nov 18, 2026
Study completion
Dec 30, 2025→Oct 14, 2027
Nov 18, 2026
Enrollment
200→345
Nov 18, 2026
Eligibility
1 inclusion criterion edited; 1 exclusion criterion edited
What changed in the criteria
Inclusion criteria
  • ChangedBefore Children older than one year oldNow Children older than one year old (older than eight years old for studies at-home) and below 18 years of age.
Exclusion criteria
  • ChangedBefore Clinical problem in the area in which the device will be attached, eg skin conditionNow Clinical problem in the area in which the device will be attached, eg skin condition ●. For patients conducting the study at home, patients with neurocognitive impairments which may increase the risk of them putting the sensor in their mouth, who do not have overnight carers
Nov 18, 2026
Interventions
Arms added: Home·Ventilation·High BMI
Nov 18, 2026
Contact
Study contact changed: o•••@acurable.com · •••7020→r•••@acurable.com · •••7020. See the current contact
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Primary completion Oct 30, 2025→Oct 14, 2027
    Study completion Dec 30, 2025→Oct 14, 2027
    Enrollment 200→345
    Eligibility 1 inclusion criterion edited; 1 exclusion criterion edited
    What changed in the criteria
    Inclusion criteria
    • ChangedBefore Children older than one year oldNow Children older than one year old (older than eight years old for studies at-home) and below 18 years of age.
    Exclusion criteria
    • ChangedBefore Clinical problem in the area in which the device will be attached, eg skin conditionNow Clinical problem in the area in which the device will be attached, eg skin condition ●. For patients conducting the study at home, patients with neurocognitive impairments which may increase the risk of them putting the sensor in their mouth, who do not have overnight carers
    Interventions Arms added: Home·Ventilation·High BMI
    Contact Study contact changed: o•••@acurable.com · •••7020→r•••@acurable.com · •••7020. See the current contact
    + 3 other changes: verification date, oversight details and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04031950
Lead sponsor
Acurable Ltd.
Collaborators
Sheffield Children's NHS Foundation Trust, University Hospital Southampton NHS Foundation Trust
Responsible party
Sponsor
First posted
Jul 25, 2019
Start date
Feb 19, 2020
Primary completion
Oct 14, 2027 (estimated)
Completion
Oct 14, 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Renard Pramono, PhD
Contact
renard@acurable.com
+447721 877020
Ruth Kingshott, PhD
study director · Sheffield Children's NHS Foundation Trust

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion